Novo Nordisk A/S NVO reported adjusted fourth-quarter 2025 earnings of $1 per American Depositary Receipt (ADR), which beat ...

Novo Nordisk shares tumbled 18% after the company issued unexpectedly weak 2026 guidance, forecasting sales could decline as much as 13%.

After federal judges blocked HHS’ 340B rebate pilot program from taking effect Jan. 1, HHS is discussing whether to reconsider the drug manufacturers’ plans, according to court documents. On Jan. 7, ...

The recent federal government shutdown, and its aftermath, has once again propelled health care to the forefront of political debate. With it comes new discussions about how to make health care ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

A federal court has blocked the implementation of the 340B rebate pilot, sparing safety-net hospitals from potential cash-flow crises and preserving upfront drug discounts for now. Revenue cycle ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Telehealth for FQHCs and RHCs: Federally qualified health centers (FQHCs) and rural health clinics (RHCs) may continue ...

The Department of Health and Human Services appears willing to take its contentious 340B Rebate Model Pilot Model back to the drawing board. After a lawsuit filed by hospitals secured a last-minute ...

China’s National Intellectual Property Administration (CNIPA) has recently released full year statistics for 2025. Overall grants (including invention, utility model and design patents) were down ...